As decision on new Alzheimer's drug nears, Biogen aims for redemption; Codeveloped with Japan's Eisai, the novel therapy for the debilitating brain disease could be approved this week.

Media coverage

• Title	As decision on new Alzheimer's drug nears, Biogen aims for redemption; Codeveloped with Japan's Eisai, the novel therapy for the debilitating brain disease could be approved this week.
  Media name/outlet	bostonglobe.com
  Country/Territory	United States
  Date	2/01/23
  Persons	Samuel Gandy

• Title	FDA decision on Alzheimer's drug has wide ramifications; Codeveloped with Japan's Eisai, the novel therapy for the debilitating brain disease could be approved this week.
  Media name/outlet	The Boston Globe
  Country/Territory	United States
  Date	2/01/23
  Persons	Samuel Gandy